Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TREMELIMUMAB Cause Multiple organ dysfunction syndrome? 16 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Multiple organ dysfunction syndrome have been filed in association with TREMELIMUMAB (IMJUDO). This represents 0.7% of all adverse event reports for TREMELIMUMAB.

16
Reports of Multiple organ dysfunction syndrome with TREMELIMUMAB
0.7%
of all TREMELIMUMAB reports
15
Deaths
11
Hospitalizations

How Dangerous Is Multiple organ dysfunction syndrome From TREMELIMUMAB?

Of the 16 reports, 15 (93.8%) resulted in death, 11 (68.8%) required hospitalization, and 9 (56.3%) were considered life-threatening.

Is Multiple organ dysfunction syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TREMELIMUMAB. However, 16 reports have been filed with the FAERS database.

What Other Side Effects Does TREMELIMUMAB Cause?

Pyrexia (178) Diarrhoea (136) Death (116) Colitis (115) Pneumonitis (87) Pneumonia (85) Sepsis (82) Vomiting (78) Febrile neutropenia (72) Malignant neoplasm progression (68)

What Other Drugs Cause Multiple organ dysfunction syndrome?

TACROLIMUS (1,847) CYCLOPHOSPHAMIDE (1,597) MYCOPHENOLATE MOFETIL (1,566) PREDNISONE (1,525) DEXAMETHASONE (1,355) METHOTREXATE (1,317) METHYLPREDNISOLONE (1,278) RITUXIMAB (1,188) PREDNISOLONE (1,154) CYCLOSPORINE (933)

Which TREMELIMUMAB Alternatives Have Lower Multiple organ dysfunction syndrome Risk?

TREMELIMUMAB vs TREMELIMUMAB\TREMELIMUMAB-ACTL TREMELIMUMAB vs TRENBOLONE TREMELIMUMAB vs TREOSULFAN TREMELIMUMAB vs TREPROSTINIL TREMELIMUMAB vs TREPROSTINIL DIOLAMINE

Related Pages

TREMELIMUMAB Full Profile All Multiple organ dysfunction syndrome Reports All Drugs Causing Multiple organ dysfunction syndrome TREMELIMUMAB Demographics